Moe Hein Aung,Machelle T. Pardue,P. Michael Iuvone
申请号：
US15105957
公开号：
US20160317474A1
申请日:
2014.12.17
申请国别(地区):
US
年份:
2016
代理人:
摘要：
This disclosure relates to managing diabetes induced visual dysfunctions or vision loss by altering levels of dopamine. In certain embodiments, the disclosure relates to methods of treating or preventing visual dysfunction or loss of vision comprising administering an effective amount of dopamine, derivative, ester, prodrug, or salt thereof to a subject wherein the subject is at risk of, exhibiting symptoms of or diagnosed with diabetes or diabetic retinopathy.
